Search Results 951-960 of 18373 for Hepatitis b

  1. A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) - Mayo Clinic

    * Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) antiviral therapy for at ...

  2. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

    Clinical or laboratory history or evidence of Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV) indicating acute or chronic infection. Any psychological ...

  3. cirrhosis Archives - Mayo Clinic News Network

    ... hepatitis infections published 4/23/18; El minuto de Mayo Clinic: El abecé de la hepatitis (The ABCs of hepatitis) ... Lewis Roberts, M.B., Ch.B., Ph.D ...

  4. Publications - Moustafa M. El Khatib, M.B., B.Ch. - Mayo Clinic

    Zeb MH, Pandian TK, El Khatib MM, Naik ND, Chandra A, Morris DS, Smoot RL, Farley DR. Risk factors for postoperative hematoma after inguinal hernia repair: ...

  5. Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant - Mayo Clinic

    Known hepatitis B or hepatitis C infection; EXCEPTION: if viral load < 800,000 IU/L; Phase I: active dermatologic disease >= grade 3. Participating Mayo ...

  6. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

    Patients with past or resolved hepatitis B infection (defined as having a negative hepatitis B surface antigen [HBsAg] test and a positive anti-HBc ...

  7. A Study to Assess the Safety and Preliminary Effectiveness of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    ... B-Cell Lymphoma (DLBCL). Print details. Share; Facebook · Twitter. Overview ... positive test results for active hepatitis B and C;; known seropositive for ...

  8. Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)™ - Mayo Clinic

    ACLF due to acute viral hepatitis A, B, B+D, C or E requiring antiviral treatment; 21. ACLF due to autoimmune hepatitis requiring high-dose steroid treatment;

  9. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

    Negative hepatitis B test (defined by a negative test for hepatitis B surface antigen [HBsAg], or antibodies to hepatitis B surface and/or core antigens ...

  10. Study of IDN-6556 in Patients With Severe AH and Contradictions to Steroid Therapy - Mayo Clinic

    Positivity for hepatitis B (HBsAg+) or C virus (HCV+); Renal failure. Exclusion Criteria: Other or concomitant cause of liver disease as a result of ...